Evaluation of the Class I histone deacetylase (HDAC) inhibitor CT-101 on fetal hemoglobin (HbF) expression in sickle progenitors and transgenic mice

CT-101 - Cetya Therap

CT 101 - Sienna

https://fscdr.org/the-symposium/

Clifford Hendrick; Biaoru Li, PhD, Betty Pace, MD, ; Jose Sangerman, PhD; Michael Boosalis, PhD;Mayuko Takezaki, MS; Louis Junker, PhD; Vy Le, PhD; Anil Shelke, PhD; Robert M Williams, PhD;Susan Perrine, MD;Betty Pace, MD

Apr 16, 2020